Skip to content
Facebook Instagram Linkedin Twitter Youtube
CoEHAR
  • Home
  • About Us
  • Laboratories
  • Projects
  • News
  • CoEHAR Play
  • Research
    • Publications
    • Repository  
  • Media Coverage
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
  • Campaigns
    • Youth Tobacco Prevention
  • Events
  • Contacts
Menu Close
Toggle the button to expand or collapse the Menu

Davide Campagna

  1. Home>
  2. Publications>
  3. Davide Campagna

Varenicline for smoking cessation in individuals who smoke cigarettes and use electronic cigarettes: a double-blind, randomised, placebo-controlled phase 3 trial

Comment on Elsayed et al. 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2023. Diabetes Care 2023;46(Suppl. 1):S68–S96 

Varenicline and counseling for vaping cessation: a double-blind, randomized, parallel-group, placebo-controlled trial

Comparing Effectiveness, tolerability, and Acceptability of Heated Tobacco ProductS vs. refillable Electronic cigarettes For cIgaREttes substitution: CEASEFIRE randomized controlled trial

Different death rates between COVID-19 waves among unvaccinated patients: moving beyond lessons learned

The Impact of Tobacco Cigarettes, Vaping Products and Tobacco Heating Products on Oxidative Stress

Taking for Granted Conclusions from Studies that Cannot Prove Causality of Respiratory Symptoms and Vaping

A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol

International Randomised Controlled Trial evaluating metabolic syndrome in type 2 Diabetic Cigarette Smokers following switching to Combustion-Free Nicotine Delivery Systems: the DIASMOKE protocol

Smoking and diabetes: dangerous liaisons and confusing relationships

Subscribe for updates.

We will send you direct emails, without intermediary services, you can withdraw in time by replying directly to the newsletter

Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.

Useful Links

  • Contacts
  • Privacy Statement (EU)
  • Cookie Policy (EU)
  • Disclaimer
Menu
  • Contacts
  • Privacy Statement (EU)
  • Cookie Policy (EU)
  • Disclaimer
Privacy Preferences

Useful Links

  • Contacts
  • Privacy Policy
  • Cookie Policy
Privacy Preferences

Mailing Address

  • Via Santa Sofia 89, 95123 Catania
  • cr.coehar@unict.it
  • 095 478.1124 - 1464

Registered Office

  • Via S.Sofia, 78 – 95123 Catania
Facebook-f Twitter Youtube Linkedin
Close Menu
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}